SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.155-7.6%Nov 13 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (3115)7/1/2010 12:47:50 PM
From: tktrimbath  Read Replies (2) of 3576
 
Is anyone working on it? Yes. But the only stem cell clinical trial I am aware of (though I haven't done extensive research) is Geron's trial for regrowing nerves.

Could someone someday get a transplant that way? The possibility certainly exists and the probability improves with time, but the FDA approval process could make that take years.

There is a lot that is uncertain about how such radical biotechnology will advance. If an accident victim can walk because of the treatment, then the news would fill the media. But getting FDA approval for a heart transplant will take how many years? That's why I bought a bit, just to be covered, but haven't jumped in more strongly.

It is fascinating to watch.

Stay tuned.

(And, Bob, I suspect that I haven't told you anything new.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext